Heart failure with preserved ejection fraction. Can we improve the prognosis of our patients?
| Autor: | Jorge Thierer |
|---|---|
| Jazyk: | Spanish; Castilian |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Revista de la Sociedad Argentina de Diabetes, Vol 56, Iss 3Sup, Pp 43-43 (2022) |
| Druh dokumentu: | article |
| ISSN: | 0325-5247 2346-9420 |
| DOI: | 10.47196/diab.v56i3Sup.583 |
| Popis: | HF with preserved EF is defined as HF with left ventricular EF ≥ 50%. Patients with slightly impaired EF, between 41 and 49%, are usually considered together with EF ≥ 50% in randomized studies. Unlike HF with depressed EF (≤40%) in which different interventions (neurohormonal antagonists, electrical therapy) have been shown to improve prognosis, until recently we did not have evidence from a randomized study in the context of EF >40%. Practice guidelines generally recommended evaluating the etiology, considering comorbidities, and controlling accompanying conditions (heart rate, blood pressure, atrial fibrillation, ischemia). In the subgroup of patients with EF between 41% and 49%, there was a IIb indication for neurohormonal antagonists in the 2021 ESC HF guideline. (1) |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|